To further explore the prognostic role of combined ERα and ERβ expression in CRC patients, we correlated the patient with combined high ERβ + negative ERα expression or combined low ERβ + positive ERα expression with proteins important in CRC development and progression (Figure 6A). Here, ESR2 is linked to colorectal carcinoma.